Grebennikova Galina Aleksandrovna - gynecologist, executive director of the Kazakhstan Association of Reproductive and Sexual Health

Specialist for the UNDP/ Global Fund Project

Samigullina Alfiya Eldarovna, Honoured Physician of the Kyrgyz Republic, Doctor of Medicine, Professor, Rector of the Bishkek International Medical Institute.

Cholpon Asambaeva has almost 22 years of experience managing development projects in public health, mother and child health, health promotion/health communication, and HR. She has medical education background from the Kyrgyz Medical Academy and a management in health from the Kyrgyz International University. Her key focus areas are project management, analytical work, and technical expertise in public health.

She used to work with UN organizations like the United Nations Population Fund, United Nations Development Fund for Women, and the World Health Organization in the position of national coordinator, project manager and senior advisor.

From 2009 to 2015 Cholpon worked for the Regional GIZ program on health in the position of Team Leader and from 2016 to 2020 she managed the components of the bilateral GIZ program on the Promotion of Perinatal Health Care in Kyrgyzstan.

From October 2020 to November 2022, Cholpon used to work at the USAID-funded Global Project “Local Health System Sustainability” in response to COVID-19 with the 6,5 USD million portfolio as a CountryD irector and supervised a team of 7 full-time staff across financial and
technical teams. Cholpon has rejoined the GIZ project Promotion of Primary Healthcare in Kyrgyzstan in December 2022 as a Technical Adviser and since February 2023 is leading this project. Cholpon has proven experience in working with government institutions and development partners, experience, and knowledge of GIZ processes and capacity development measures.

Lead Specialist of the Ministry of Health of the Kyrgyz Republic

Sir Harry Burns is Professor of Global Public Health, at the University of Strathclyde, and formerly Chief Medical Officer for Scotland.

He began his career in general surgery, and for five years he was a consultant surgeon at the Glasgow Royal Infirmary and subsequently became its Medical Director. Sir Harry completed a Masters Degree in Public Health in 1990 and, in 1993, became Director of Public Health for Greater Glasgow. In September 2005 he was appointed Chief Medical Officer for Scotland. His legacy in this post includes his ground-breaking work on the importance of the early years as the basis for health and wellbeing in adulthood, along with tackling issues of health and social inequality. In April 2014 Sir Harry stood down to take up his current role as Professor of Global Public Health at Strathclyde University. In December that year he was also presented with the Lifetime Achievement Award at the first Scottish Public Service Awards, recognising his lasting contribution to public service in Scotland.

Dr Manuel Carballo in an Executive Director of the International Centre for Migration, Health and Development (ICMHD) in Switzerland.

Born in Gibraltar, Dr Carballo studied in the UK. In a distinguished career he has worked with the United Nations and World Health Organization in a number of countries. His areas of expertise extend to HIV/AIDS, post-conflict and disaster relief and reconstruction and refugee crisis response and management. In 1995 he set up the International Centre for Migration and Health, a Swiss based research and training organisation, and has continued his work through this. He is also adjunct Professor of Clinical Public Health at the Columbia School of Public Health, in the US.

Ross Coomber is currently Professor of Criminology and Sociology at the University of Liverpool. Prior to this he was Professor and Director of the Griffith Criminology Institute, Griffith University, in Brisbane and Gold Coast Australia, and before that, Professor of Sociology, and Director of the Drug and Alcohol Research Unit at the University of Plymouth. He has more than 30 years research experience in the drug and alcohol field and has published extensively and broadly in this area - particularly on the nature risk as it applies to drug use and illicit drug markets, nationally and internationally, and across different cultural and environmental spaces. His research is strongly inter/multidisciplinary and boasts ongoing collaborations with forensic chemists/scientists, medics, public health practitioners and researchers, as well as, perhaps more predictably, disciplines across the humanities and social sciences. In 2013 he undertook a rapid ethnographic and cross-cultural observational tour of six Asian countries/cities (China/Shanghai; India/Mumbai; Indonesia/Jakarta; Japan/Tokyo; Malaysia/Kuala Lumpa South Korea/Seoul) looking at the nature and meaning of public spitting in those locales. He is currently an Adjunct Professor of the Griffith Criminology Institute, Griffith University, Australia as well as at the School of Justice, Queensland University of Technology, Brisbane, Australia.

Dr. Jiang Du M.D. is a psychiatrist of Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine. She has worked in the drug abuse field for almost 20 years with a research focus on drug abuse prevention and intervention.  She has also conducted research on drug abuse and HIV/HCV-related risk behaviors among intravenous drug users. She was a Principal Investigator of  study on the influence of drug-related cue exposure on heroin dependence relapsing (funded by Shanghai Mental Health Center), and she has participated as a co-Investigator in other drug abuse research projects funded by Shanghai Health Bureau and NIH.

Ms. Begaiym Egimbaeva operates as a Communications Officer at the Swiss project “Effective Management and Prevention of Noncommunicable Diseases in Kyrgyzstan”. In 2019 she obtained her MA degree in Journalism and Mass Communication at American University of Central Asia (AUCA), Bishkek, Kyrgyzstan.

In 2019 Begaiym attended SSPH+ Lugano Summer School in Public Health Policy, Economics, and Management. She also was a participant of DataFest Tbilisi in 2019, which is an annual international data event in South Caucasus supporting cross-sector and cross-border cooperation, strengthening communities and inspiring individuals to pursue and explore opportunities created by data and technology.

Professor Marewa Glover has worked on reducing smoking-related harm for over 25 years. She has worked as a policy analyst, a co-ordinator of a national tobacco control programme, cessation trainer and, for over 17 years, as a researcher. She has chaired numerous committees and organisations including End Smoking NZ, an independent NGO that lobbied for a harm reduction approach even before electronic cigarettes were introduced. Marewa has over 100 publications reflecting her leadership and support of numerous studies. Her primary focus has been reducing smoking during pregnancy and reducing smoking among Māori, the indigenous people of New Zealand. She has also been a co-investigator on a number of innovative cessation projects and a longitudinal online survey of New Zealand vapers. Dr Glover is the most prominent public commentator on vaping in NZ. She is regularly called by the media and has appeared on NZ’s 60 Minutes in addition to participating in live online and conference debates about vaping. Despite an initial ban on the import and sale of nicotine for vaping imposed by the Ministry of Health, vaping has become established as a common and successful way to reduce or stop smoking in NZ. Marewa, along with a small number of other researchers who early on foresaw the potential of ecigs, have helped make this happen.

Professor Michel Kazatchkine is UN Special Envoy for HIV/AIDS in Eastern Europe and Central Asia.

Kazatchkine has spent the past 25 years fighting AIDS and working to improve global health as a leading physician, researcher, advocate, policymaker, diplomat and administrator.

He attended medical school at Necker-Enfants-Malades in Paris, studied immunology at the Pasteur Institute and completed postdoctoral fellowships at St Mary’s hospital in London and Harvard Medical School.

His involvement with HIV began in 1983, when as a young clinical immunologist he treated a French couple who had returned from Africa with unexplained fever and severe immune deficiency. By 1985, he had started a clinic in Paris specialising in AIDS, which now treats over 1,600 people.

From 1998 to 2005, Professor Kazatchkine directed the French National Research Agency (ANRS), the world’s second largest AIDS research programme. He has produced more than 600 research papers focusing on auto-immunity, drug therapy, immuno-intervention and HIV pathogenesis, in addition to serving on numerous editorial boards.

From 2005 to 2007, Professor Kazatchkine was France’s global ambassador for HIV/AIDS and transmissible diseases. As Ambassador he championed France’s contributions to achieving the Millennium Development Goals and the establishment of Unitaid.

In 2007 he was elected as Executive Director of the Global Fund to Fight AIDS, Malaria and Tuberculosis. In his five years at the helm of the Fund, more than $20 billion in additional donor commitments and pledges were mobilised and he oversaw a major expansion of the Global Fund’s operations and grant portfolio, establishing the Fund as the major international financer of health programs. He strongly emphasised the Fund’s role as a model partnership for development at the national and global levels and promoted innovative approaches to health financing, including Debt2Health and the Affordable Medicines Facility for Malaria. His leadership of the Global Fund consolidated his reputation as one of the world’s leading advocates for health and human rights.

In 2012, Professor Kazatchkine was appointed as the UN Secretary General‘s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia, the part of the world where the AIDS epidemic is expanding at the fastest rate.

Kentra Gintautas-Jouzas is a cardiologist, Deputy Chairman of the Council and member of the Expert Council of the Densaulyk ULL.

Rakhypbekov Tolebay Kosiyabekovich - MD, PhD, professor, president of the National Association "Primary Health Care".

Katarzyna Kinga Kowalczyk holds MA in Psychology and History and PhD in Economics (in the field of Management). Her area of experience includes harm reduction, public health and event management. She is running the Global Public Health Foundation, aimed to share research and experience in public health across all relevant sectors. She is also a lecturer at the University of Social Sciences and Humanities.

Social psychologist & IT specialist, author of publications on psychology, data analysis and harm reduction. Since 2003 Grzegorz manages international projects in the area of public health, drugs and tobacco harm reduction. Between 2012 and 2018 lecturer at the Faculty of Management & MBA School, University of Warsaw. Since 2016, member of the European Network for Research Evaluation in the Social Sciences and the Humanities (ENRESSH), part of the COST Action: European Cooperation in Science and Technology. Co-founder of a harm reduction knowledge hub at harmreduction.eu.

Chairman of the Association of Nursing Professionals

Dumitru is a physician and worked as a surgeon at the Central Penitentiary Hospital in Republic of Moldova since 1995. From 1997 to 1999 he was involved in designing, from 2000 to 2003 in managing and from 2003 to 2006 in advising the prison tuberculosis programme for the Republic of Moldova. In 2000 he designed and implemented the pilot project on needle and syringe exchange in prisons of the Republic of Moldova. From 2003 to 2006 he managed the Republic of Moldova’s Tuberculosis (TB)/IDA Programme Implementation Unit, financed by the World Bank and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Since 2006, Dumitru has been working at the Global Fund, as the Fund Portfolio Manager for tuberculosis, HIV and malaria grants for several eastern European countries.

David MacKintosh has spent two decades working in drug and alcohol policy. This has included experience at national level (Cabinet Office), regional (Greater London Authority) and local civic levels (City of London). From 2001 – 2020 he led the work of the London Drug and Alcohol Policy Forum including its involvement in the 2006-07 AGIS programme undertaking a threat assessment in relation to methamphetamine and was a supporter of the Club Health – Healthy and Safer Nightlife of Youth Project 2008-2013. His work around improving safety in the night time economy, relaunched in early 2020, is acknowledged as the UK best practice guidance and has informed work internationally.

Dave is a qualified Mental Health Nurse, qualifying in 1999 from the University of Central Lancashire. Prior to that he had had various roles in acute psychiatric intensive care units. Following several years working in forensic mental health he began to specialise in substance misuse and the crossover between Mental Health, Substance Misuse and Criminal Justice, including running Drug Rehabilitation Requirements in Blackpool as part of the well regarded Tower Project.

In 2014 he embarked on a secondment with Combat Stress, a veterans’ mental health charity, to pilot a service to enable and encourage veterans with military- related PTSD and substance misuse issues to access the services they need, in order to address these complex issues: issues that neither drug services, criminal justice services, nor mainstream mental health services alone were able to address.

Before long it became clear that there were many veterans becoming lost in the criminal justice system due to undiagnosed PTSD, complicated by substance misuse, and that their substance misuse was preventing them from accessing quality treatment for their PTSD issues. Veterans are the single largest professional group involved with the criminal justice system. The project that Dave has been key in developing aims to target veterans who may have been misdiagnosed, or undiagnosed, in order to ensure that they receive the treatment they deserve (prevention) or the diagnosis they need (diversion) in order they receive optimum care packages.

He was given this year’s the Paolo Pertica award for his innovative approach in developing care pathways, which led to swifter diagnosis of PTSD, allowing a more effective multi-agency response for those in need of help.

Currently, he works for the Institute for Addiction Research and the Frankfurt University of Applied Sciences as International Scientific Coordinator of the DAAD exceed project "Social Work and strengthening of NGOs in development cooperation to treat drug addiction SOLID". Until 2019 he was also the coordinator of the EU Drugs Action Program in Central Asia (CADAP) for Frankfurt University. For a long period he was the head of the office of various drug commissioners of the federal government in the Federal Ministry of Health in Berlin (1999-2017) (with intermittent stays abroad). He retired in April 2017.

As a sociologist and consultant for the treatment of drug addiction, he was head of the drug and prison projects of the German AIDS Help in Berlin (1987-1994), as well as drug commissioner for the state of Bremen (1994-1998). From 2006 to 2008 he worked with the Shanghai Mental Health Center and the Beijing National Institute of Drug Dependence and was able to support the implementation of methadone treatment programs in the People's Republic of China. He was visiting professor and lectured on social work for drug addicts at the East China University of Technology and Science in Shanghai. 

From 2010 to 2013 he worked as a project manager in the 5th phase of the Central Asia Drug Action Program (CADAP) of the European Union in Bishkek, Kyrgyz Republic, under the leadership of GIZ (German Society for International Cooperation). He worked with the health department of the United Nations Office on Drugs and Crime (UNODC) in Vienna.

Dr. Michels has published numerous articles in international journals on substance use and the treatment of drug use disorders and on HIV / AIDS prevention and treatment.

Dalida Mukasheva was the coordinator and worked on significant projects such as the UNICEF project «Strengthening the prevention and response of the health system to violence against children and adolescents»; The World Bank project "Social Health Insurance" task 3 "Informing the population on priority issues of public health protection"; the Management Plan for the implementation of the State program for improving the health of the population of the Republic of Kazakhstan for 2020-2025; Health Promoting Schools and Healthy Cities projects. 

Dalida Mukasheva takes part in activities aimed at developing and supporting public health and is a participant in significant projects through the World Bank, the Ministry of Health, WHO, UNICEF

Doctor, Chairperson of the Board of the "National Association for Harm Reduction of Human Health Risk Factors - "Densaulyk", Member of the Expert Council of "Densaulyk"

Fredrik Nyström is a professor of internal medicine and endocrinology at Linköping University in Sweden. He’s also the chief physician of internal medicine in his clinic, where he primarily treats patients with diabetes or those who are overweight.

Omurkanova Cholpon Askerbekovna, Director of the Egl Public Foundation, ex-Chairman of the Public Council of the State Penitentiary Service of the Kyrgyz Republic from April 2011 to June 2021, independent expert on the reform of the penitentiary system. Mediator, conflictologist. Higher pedagogical and legal education. Co-author of the National Strategy for the Reform and Development of the Penitentiary System (2012-2016, 2018-2023 and 2024-2027)

Dr Ulla Pape is a political scientist and research associate (postdoc) at the Institute of Addiction Research at the Frankfurt University of Applied Sciences. She holds a Ph.D. in International Relations and International Organization from the University of Groningen.

Before joining the SOLID project in 2022, Ulla was research associate (postdoc) at the Otto Suhr Institute of Political Science at the Freie Universität Berlin, lecturer in European Studies at the University of Bremen, research associate (postdoc) in the Third Sector Impact project at Radboud University Nijmegen, and senior researcher at the International Laboratory for Non-profit Sector Studies at the Higher School of Economics in Moscow.

Her research interests include international health and social policy, welfare state development and civil society in Eastern Europe and Central Asia. Ulla has published a book The Politics of HIV/Aids in Russia (2014) and several articles in international journals such as Europe-Asia Studies, the Journal of Civil Society, the International Journal for Sociology and Social Policy, and Voluntas.

In the SOLID project, Ulla is responsible for the research on social work in the prisons and social work and infectious diseases (HIV, HCV and tuberculosis). Furthermore, she focuses on the participation with civil society actors in developing social work in Central Asia. Next to her project responsibilities, Ulla is member of the editorial board of Voluntas and associate lecturer at the Freie Universität Berlin.

Fiona Patten was a member of the Victorian parliament in Australia from 2014 to 2022. She campaigned on harm reduction policies for 30 years and ran the adult industry association (Eros) for 20 years. She initiated and delivered reforms including voluntary assisted dying, abortion law reform, the decriminalisation of sex work and drug law reform.

Since leaving parliament she has continued to work on social reform issues including medicinal cannabis, drug harm reduction including for tobacco, criminal justice reform and greater separation of church and state.

In 2018 she published her autobiography -‘Sex, Drugs and the Electoral Roll’. She is also the owner of a registered wildlife sanctuary.

Petukhova Nadezhda Mikhailovna - Chairman of the Public Council of the Ministry of Health of the Republic of Kazakhstan; Chairman of the Board of the Eurasian Medical Association. President of the City Branch of the Kazakhstan Association for Sexual and Reproductive Health, Astana. Astana. Deputy of the Majilis of the Parliament of the Republic of Kazakhstan of the 5th convocation.

Mariya Prilutskaya is an Assistant researcher in the Department of Personalized Medicine and Department of Public Health at Pavlodar branch of Semey Medical University in Pavlodar, and a Psychotherapist in the Department of Psychotherapy and Rehabilitation of the Republican Scientific and Practical Center for Medical and Social Problems of Drug Addiction in Pavlodar city.

She received a bachelor’s degree in psychiatry from the Medical University of Astana and master degree in medicine from Semey State Medical University, She is interested in addiction psychiatry, clinical challenges of novel psychoactive substances, scientific researches and new educational technologies. She is skilled in statistical analysis, including SPSS and R.

Amir Rashidov is a drug addiction clinician in the Republican Specialized Scientific and Practical Drug Treatment Medical Center in Uzbekistan. He has been working in the addiction field professionally since 2015. He was a study visitor at the EMCDDA, and he was involved in the project/research on the Treatment Demand Indicator in 2019. Moreover, he is engaged in a pilot assessment of the quality of drug treatment services in Uzbekistan.

Urazalieva Ilmira Ravkatovna PhD assistant professor at the School of Public Health, Tashkent Medical Academy, specialist in public health and health care management.

Julia Rozanova is an Associate Research Scientist at the AIDS Program of the Yale School of Medicine. She received her PhD in Sociology (Alberta) and subsequently trained in Social Gerontology (Brown) and Implementation Science (Yale). Since 2018, she has had the privilege of leading a research program on HIV prevention and treatment among vulnerable populations in prison and community contexts in Eastern Europe and Central Asia. With colleagues from the AIDS Foundation East West Kyrgyzstan Dr Rozanova has conducted a clinical trial of a bespoke peer-driven intervention to improve the mental health and reduce HIV risk among prisoners with a history of injection drug use in Bishkek, Kyrgyzstan. With colleagues from the European Institute on Public Health Policy, Dr Rozanova has examined the intersection of HIV, addiction, and aging in Ukraine. During the Covid-19 pandemic and subsequently during the war, Dr Rozanova has led clinical trials of interventions to bring older people with HIV into care using peer navigation strategy and provide them with an evidence-based decision aid to inform HIV status disclosure. Over the last year, Dr Rozanova’s research has increasingly focused on how both service users and healthcare workers cope during the humanitarian crisis and factors underlying their resilience. Dr Rozanova’s work has been supported by grants from the American Medical Foundation, Center for Interdisciplinary Research on AIDS,  MacMillan Center for International Studies, and Fund for Lesbian and Gay Studies at Yale University; the National Institute on Drug Abuse (K01DA047194), the National Institute on Aging (R21AG072961 and R21AG072961-02S1), and the National Institute of Mental Health (R34MH130260).

Ruth Dreifuss (born in 1940, single) studied in Geneva where she received a degree in economics with special focus on econometrics in 1971. In her varied professional career she served as hotel secretary, editor of the weekly journal Coopération, social worker, assistant at the Geneva University. She then worked nine years for the Swiss Agency for Development and Humanitarian Aid (Federal Department of Foreign Affairs) and became in 1981 Secretary of the Swiss Labour Union Federation. In that capacity, she was responsible for sectors including social insurance, labour law, gender equality and relations with the International Labour Organization (ILO). As responsible for public health and social insurance, she implemented a new policy in the fields of drug addiction and prevention of HIV/AIDS. She was also in charge with the introduction of the new law on health insurance, which guaranties a universal coverage for the Swiss population. After her retirement from government, she contributed to the WHO report on intellectual property rights, innovation and public health. v

Solovieva Aigul Sagadibekovna - Chairman of the Board of ALE "Association of Environmental Organizations of Kazakhstan". Member of the Human Rights Commission under the President of the Republic of Kazakhstan, member of the Council on Protection of Entrepreneurs' Rights and Counteraction to Corruption of the National Chamber of Entrepreneurs of the Republic of Kazakhstan "Atameken". Deputy of the Majilis of the Parliament of the Republic of Kazakhstan of the 5th convocation.

Nurgozhin Talgat Seitzhanovich - MD, PhD, professor. Head of the Department at Al-Farabi Kazakh State University.

Harry is the Director of DrugWise the international Knowledge hub, promoting evidence-based information on drugs, alcohol and tobacco.

He has worked in the drugs field for over 35 years, most recently as Director of Communications for DrugScope. He was DrugScope’s main media spokesperson, managing editor of Druglink and has written extensively on all aspects of drugs and drug-related issues combining this with lecturing, public speaking and advisory work for government. He remains the managing editor of DS Daily.

The title for Harry’s 2016 Alison Chesney and Eddie Killoran lecture was: ‘The Needle and the Damage Done’; drug users, media and stigma

The executive director of AFEW-Kyrgyzstan

Sergey Soshnikov is working as a Vice-Rector for international affairs at the Bukhara State Medical Institute in Uzbekistan. He began his career in healthcare in Russia in 2000. From 2003 to 2008, he received an education and a Ph.D. at the Russian Research Institute of Health. During his study as a Ph.D. student, he worked in the International Department of RRIH as a monitoring expert in the international projects of the Global Foundation. From 2010 – 2016, he worked as an assistant professor at the Department for Medical Statistics and Informatics at the Russian Medical Academy of Postgraduate Education in Moscow. From 2011 – 2012 he obtained a Fulbright grant and worked as a visiting researcher at Mathematics Department at Central Michigan University in the USA. From 2013 to 2016, he developed and led the Mathematical Modelling in Healthcare Department, and from 2018 to 2021, he served as a researcher at the Department of Research Planning and Management in the Federal Public Health Research Institute. From December 2015 to January 2016, he worked as an expert consultant for World Health Organization Regional Office for Europe. From 2016 – 2018, he continued his career as head of the Department and Chief Specialist at the Center for Healthcare Quality Assessment and Control of the Ministry of Health. From September 2019 to March 2022 worked as a Researcher at the Moscow Institute of Physics and Technology (MIPT). From 2021 to 2022, he worked as a Professor at Sechenov First Moscow State Medical University. 

Professor Gerry Stimson is a leading advocate for tobacco harm reduction and an Emeritus Professor at Imperial College London. A public health social scientist, with over 50 years’ experience of research and advocacy, he was one of the founders of drugs harm reduction in the 1990s, helping to develop and evaluate harm reduction in the UK as a response to HIV/AIDS. Gerry has advised the UK Government, WHO, UNAIDS, UNODC, the World Bank and numerous governments around the world on issues relating to drugs, HIV infection and AIDS, and alcohol. He has also published over 220 scientific publications and several books. 

Currently, Gerry is Director of Research and Policy at Knowledge•Action•Change, and is involved in the FSFW-funded Global State of Tobacco Harm Reduction and Tobacco Harm Reduction Scholarship programmes. He is also a co-founder of the Global Forum on Nicotine, which has been delivered by KAC Communications since 2014. 

Heino Stöver is a social scientist, PhD and Professor of Social Scientific Addiction Research at the Frankfurt University of Applied Sciences in Germany, Faculty of Health and Social Work. Since 1987 he has been director of the Archive and Documentation Centre for Drug Literature and Research at the University of Bremen (www.archido.info). He is the president of the national umbrella organisation working on harm reduction for drug users, called akzept e.V. (Bundesverband für akzeptierende Drogenarbeit und humane Drogenpolitik; www.akzept.eu ). Since 2009 he is the director of the “Institute of Addiction Research” (Frankfurt-university.de/isff).

Heino Stöver’s main fields of research and project development expertise are health promotion for vulnerable and marginalized groups, drug services, prison health care and related health issues (especially HIV/AIDS, Hepatitis C, drug dependence, and gender issues), and the potential of e-cigarettes. His international research and consultancy expertise includes working as a consultant for the European Commission, United Nations Office on Drugs and Crime (UNODC), World Health Organization (WHO), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), International Committee of the Red Cross (ICRC) and Open Society Institute (OSI) in various contexts.

He has published several articles in peer reviewed international journals and books on preventing and treating infectious diseases adequately (HIV/AIDS, hepatitis, STIs, and TB), opioid substitution programmes (including the provision of heroin) in the community and in prisons, and general health care issues. He is co-founder of the International Journal of Prisoner Health ( https://www.researchgate.net/profile/Heino_Stoever). Heino Stöver has gained project experiences by participating in and leading of several projects in the European Union, Africa, Central Asia, and Asia ( https://twitter.com/HeinoStoever).